Open innovation for new drug research in Indian pharmaceutical sector

The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.